Evaluation of new neuromuscular blocking agents.
D000731:Androstanes / Q000494:pharmacology; D000818:Animals; D002415:Cats; D004285:Dogs; D006801:Humans; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects*; D009467:Neuromuscular Depolarizing Agents / Q000008:administration & dosage / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D011955:Receptors, Drug; D011984:Sensory Receptor Cells / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects*; D013678:Technology, Pharmaceutical; D014403:Tubocurarine / Q000378:metabolism
D000731:Androstanes; D009467:Neuromuscular Depolarizing Agents; D010880:Piperidines; D011955:Receptors, Drug; D014403:Tubocurarine